Codiak BioSciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
Codiak BioSciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $3.02 million as of 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2022-05-05
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $3.02M.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $9.37M.
- 2021-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $21.97M.
- 2021-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $30.45M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2022-03-31 | $3.02M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $9.37M 10-K · filed 2022-03-10 |
| 2021-09-30 | $21.97M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $30.45M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $22.24M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $65.59M 10-K · filed 2021-03-17 |
| 2020-09-30 | $20.66M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $8.57M 10-Q · filed 2020-11-19 |